3RHX - JenaLib

Asymmetric Unit (33, 66)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_069292	R	470	L	FGFR1_HUMAN	Disease (HH2)	121909637	A/B	R	470	L
02	UniProt	VAR_069956	P	483	T	FGFR1_HUMAN	Disease (HH2)	397515444	A/B	P	483	T
03	UniProt	VAR_070853	G	490	R	FGFR1_HUMAN	Disease (HRTFDS)	869025670	A/B	G	490	R
04	UniProt	VAR_030995	A	520	T	FGFR1_HUMAN	Disease (HH2)	749758370	A/B	A	520	T
05	UniProt	VAR_030996	I	538	V	FGFR1_HUMAN	Disease (HH2)	---	A/B	I	538	V
06	UniProt	VAR_075853	N	546	K	FGFR1_HUMAN	Disease (ECCL)	---	A/B	N	546	K
07	UniProt	VAR_075854	V	561	M	FGFR1_HUMAN	Polymorphism	---	A/B	V	561	M
08	UniProt	VAR_017889	V	607	M	FGFR1_HUMAN	Disease (HH2)	121909629	A/B	V	607	M
09	UniProt	VAR_069293	K	618	N	FGFR1_HUMAN	Disease (HH2)	---	A/B	K	618	N
10	UniProt	VAR_030997	H	621	R	FGFR1_HUMAN	Disease (HH2)	---	A/B	H	621	R
11	UniProt	VAR_030998	R	622	G	FGFR1_HUMAN	Disease (HH2)	---	A/B	R	622	G
12	UniProt	VAR_030999	R	622	Q	FGFR1_HUMAN	Disease (HH2)	---	A/B	R	622	Q
13	UniProt	VAR_070854	D	623	Y	FGFR1_HUMAN	Disease (HRTFDS)	398122946	A/B	D	623	Y
14	UniProt	VAR_071460	R	627	T	FGFR1_HUMAN	Disease (HRTFDS)	869025671	A/B	R	627	T
15	UniProt	VAR_070855	N	628	K	FGFR1_HUMAN	Disease (HRTFDS)	869025672	A/B	N	628	K
16	UniProt	VAR_075855	K	656	E	FGFR1_HUMAN	Disease (ECCL)	869320694	A/B	K	656	E
17	UniProt	VAR_042203	V	664	L	FGFR1_HUMAN	Unclassified	---	A/B	V	664	L
18	UniProt	VAR_017890	W	666	R	FGFR1_HUMAN	Disease (HH2)	---	A/B	W	666	R
19	UniProt	VAR_069957	E	670	K	FGFR1_HUMAN	Disease (HH2)	397515446	A/B	E	670	K
20	UniProt	VAR_069294	A	671	P	FGFR1_HUMAN	Disease (HH2)	---	A/B	A	671	P
21	UniProt	VAR_031000	S	685	F	FGFR1_HUMAN	Disease (HH2)	---	A/B	S	685	F
22	UniProt	VAR_031001	G	687	R	FGFR1_HUMAN	Disease (HH2)	727505376	A/B	G	687	R
23	UniProt	VAR_069958	E	692	G	FGFR1_HUMAN	Disease (HH2)	397515445	A/B	E	692	G
24	UniProt	VAR_031002	I	693	F	FGFR1_HUMAN	Disease (HH2)	---	A/B	I	693	F
25	UniProt	VAR_031003	G	703	R	FGFR1_HUMAN	Disease (HH2)	---	A/B	G	703	R
26	UniProt	VAR_031004	G	703	S	FGFR1_HUMAN	Disease (HH2)	768957161	A/B	G	703	S
27	UniProt	VAR_017891	M	719	R	FGFR1_HUMAN	Disease (HH2)	---	A/B	M	719	R
28	UniProt	VAR_074014	M	719	V	FGFR1_HUMAN	Unclassified (HH2)	---	A/B	M	719	V
29	UniProt	VAR_031005	P	722	H	FGFR1_HUMAN	Disease (HH2)	267606805	A/B	P	722	H
30	UniProt	VAR_031006	P	722	S	FGFR1_HUMAN	Disease (HH2)	121909642	A/B	P	722	S
31	UniProt	VAR_031007	N	724	K	FGFR1_HUMAN	Disease (HH2)	267606806	A/B	N	724	K
32	UniProt	VAR_070856	C	725	Y	FGFR1_HUMAN	Disease (HRTFDS)	398122945	A/B	C	725	Y
33	UniProt	VAR_031008	P	745	S	FGFR1_HUMAN	Disease (HH2)	---	A/B	P	745	S

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (33, 33)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_069292	R	470	L	FGFR1_HUMAN	Disease (HH2)	121909637	B	R	470	L
02	UniProt	VAR_069956	P	483	T	FGFR1_HUMAN	Disease (HH2)	397515444	B	P	483	T
03	UniProt	VAR_070853	G	490	R	FGFR1_HUMAN	Disease (HRTFDS)	869025670	B	G	490	R
04	UniProt	VAR_030995	A	520	T	FGFR1_HUMAN	Disease (HH2)	749758370	B	A	520	T
05	UniProt	VAR_030996	I	538	V	FGFR1_HUMAN	Disease (HH2)	---	B	I	538	V
06	UniProt	VAR_075853	N	546	K	FGFR1_HUMAN	Disease (ECCL)	---	B	N	546	K
07	UniProt	VAR_075854	V	561	M	FGFR1_HUMAN	Polymorphism	---	B	V	561	M
08	UniProt	VAR_017889	V	607	M	FGFR1_HUMAN	Disease (HH2)	121909629	B	V	607	M
09	UniProt	VAR_069293	K	618	N	FGFR1_HUMAN	Disease (HH2)	---	B	K	618	N
10	UniProt	VAR_030997	H	621	R	FGFR1_HUMAN	Disease (HH2)	---	B	H	621	R
11	UniProt	VAR_030998	R	622	G	FGFR1_HUMAN	Disease (HH2)	---	B	R	622	G
12	UniProt	VAR_030999	R	622	Q	FGFR1_HUMAN	Disease (HH2)	---	B	R	622	Q
13	UniProt	VAR_070854	D	623	Y	FGFR1_HUMAN	Disease (HRTFDS)	398122946	B	D	623	Y
14	UniProt	VAR_071460	R	627	T	FGFR1_HUMAN	Disease (HRTFDS)	869025671	B	R	627	T
15	UniProt	VAR_070855	N	628	K	FGFR1_HUMAN	Disease (HRTFDS)	869025672	B	N	628	K
16	UniProt	VAR_075855	K	656	E	FGFR1_HUMAN	Disease (ECCL)	869320694	B	K	656	E
17	UniProt	VAR_042203	V	664	L	FGFR1_HUMAN	Unclassified	---	B	V	664	L
18	UniProt	VAR_017890	W	666	R	FGFR1_HUMAN	Disease (HH2)	---	B	W	666	R
19	UniProt	VAR_069957	E	670	K	FGFR1_HUMAN	Disease (HH2)	397515446	B	E	670	K
20	UniProt	VAR_069294	A	671	P	FGFR1_HUMAN	Disease (HH2)	---	B	A	671	P
21	UniProt	VAR_031000	S	685	F	FGFR1_HUMAN	Disease (HH2)	---	B	S	685	F
22	UniProt	VAR_031001	G	687	R	FGFR1_HUMAN	Disease (HH2)	727505376	B	G	687	R
23	UniProt	VAR_069958	E	692	G	FGFR1_HUMAN	Disease (HH2)	397515445	B	E	692	G
24	UniProt	VAR_031002	I	693	F	FGFR1_HUMAN	Disease (HH2)	---	B	I	693	F
25	UniProt	VAR_031003	G	703	R	FGFR1_HUMAN	Disease (HH2)	---	B	G	703	R
26	UniProt	VAR_031004	G	703	S	FGFR1_HUMAN	Disease (HH2)	768957161	B	G	703	S
27	UniProt	VAR_017891	M	719	R	FGFR1_HUMAN	Disease (HH2)	---	B	M	719	R
28	UniProt	VAR_074014	M	719	V	FGFR1_HUMAN	Unclassified (HH2)	---	B	M	719	V
29	UniProt	VAR_031005	P	722	H	FGFR1_HUMAN	Disease (HH2)	267606805	B	P	722	H
30	UniProt	VAR_031006	P	722	S	FGFR1_HUMAN	Disease (HH2)	121909642	B	P	722	S
31	UniProt	VAR_031007	N	724	K	FGFR1_HUMAN	Disease (HH2)	267606806	B	N	724	K
32	UniProt	VAR_070856	C	725	Y	FGFR1_HUMAN	Disease (HRTFDS)	398122945	B	C	725	Y
33	UniProt	VAR_031008	P	745	S	FGFR1_HUMAN	Disease (HH2)	---	B	P	745	S

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 2 (33, 33)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_069292	R	470	L	FGFR1_HUMAN	Disease (HH2)	121909637	A	R	470	L
02	UniProt	VAR_069956	P	483	T	FGFR1_HUMAN	Disease (HH2)	397515444	A	P	483	T
03	UniProt	VAR_070853	G	490	R	FGFR1_HUMAN	Disease (HRTFDS)	869025670	A	G	490	R
04	UniProt	VAR_030995	A	520	T	FGFR1_HUMAN	Disease (HH2)	749758370	A	A	520	T
05	UniProt	VAR_030996	I	538	V	FGFR1_HUMAN	Disease (HH2)	---	A	I	538	V
06	UniProt	VAR_075853	N	546	K	FGFR1_HUMAN	Disease (ECCL)	---	A	N	546	K
07	UniProt	VAR_075854	V	561	M	FGFR1_HUMAN	Polymorphism	---	A	V	561	M
08	UniProt	VAR_017889	V	607	M	FGFR1_HUMAN	Disease (HH2)	121909629	A	V	607	M
09	UniProt	VAR_069293	K	618	N	FGFR1_HUMAN	Disease (HH2)	---	A	K	618	N
10	UniProt	VAR_030997	H	621	R	FGFR1_HUMAN	Disease (HH2)	---	A	H	621	R
11	UniProt	VAR_030998	R	622	G	FGFR1_HUMAN	Disease (HH2)	---	A	R	622	G
12	UniProt	VAR_030999	R	622	Q	FGFR1_HUMAN	Disease (HH2)	---	A	R	622	Q
13	UniProt	VAR_070854	D	623	Y	FGFR1_HUMAN	Disease (HRTFDS)	398122946	A	D	623	Y
14	UniProt	VAR_071460	R	627	T	FGFR1_HUMAN	Disease (HRTFDS)	869025671	A	R	627	T
15	UniProt	VAR_070855	N	628	K	FGFR1_HUMAN	Disease (HRTFDS)	869025672	A	N	628	K
16	UniProt	VAR_075855	K	656	E	FGFR1_HUMAN	Disease (ECCL)	869320694	A	K	656	E
17	UniProt	VAR_042203	V	664	L	FGFR1_HUMAN	Unclassified	---	A	V	664	L
18	UniProt	VAR_017890	W	666	R	FGFR1_HUMAN	Disease (HH2)	---	A	W	666	R
19	UniProt	VAR_069957	E	670	K	FGFR1_HUMAN	Disease (HH2)	397515446	A	E	670	K
20	UniProt	VAR_069294	A	671	P	FGFR1_HUMAN	Disease (HH2)	---	A	A	671	P
21	UniProt	VAR_031000	S	685	F	FGFR1_HUMAN	Disease (HH2)	---	A	S	685	F
22	UniProt	VAR_031001	G	687	R	FGFR1_HUMAN	Disease (HH2)	727505376	A	G	687	R
23	UniProt	VAR_069958	E	692	G	FGFR1_HUMAN	Disease (HH2)	397515445	A	E	692	G
24	UniProt	VAR_031002	I	693	F	FGFR1_HUMAN	Disease (HH2)	---	A	I	693	F
25	UniProt	VAR_031003	G	703	R	FGFR1_HUMAN	Disease (HH2)	---	A	G	703	R
26	UniProt	VAR_031004	G	703	S	FGFR1_HUMAN	Disease (HH2)	768957161	A	G	703	S
27	UniProt	VAR_017891	M	719	R	FGFR1_HUMAN	Disease (HH2)	---	A	M	719	R
28	UniProt	VAR_074014	M	719	V	FGFR1_HUMAN	Unclassified (HH2)	---	A	M	719	V
29	UniProt	VAR_031005	P	722	H	FGFR1_HUMAN	Disease (HH2)	267606805	A	P	722	H
30	UniProt	VAR_031006	P	722	S	FGFR1_HUMAN	Disease (HH2)	121909642	A	P	722	S
31	UniProt	VAR_031007	N	724	K	FGFR1_HUMAN	Disease (HH2)	267606806	A	N	724	K
32	UniProt	VAR_070856	C	725	Y	FGFR1_HUMAN	Disease (HRTFDS)	398122945	A	C	725	Y
33	UniProt	VAR_031008	P	745	S	FGFR1_HUMAN	Disease (HH2)	---	A	P	745	S

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

PROSITE Motifs (2, 4)

Exons (0, 0)

Sequences/Alignments

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:289
 aligned with FGFR1_HUMAN | P11362 from UniProtKB/Swiss-Prot  Length:822

    Alignment length:301
                                   473       483       493       503       513       523       533       543       553       563       573       583       593       603       613       623       633       643       653       663       673       683       693       703       713       723       733       743       753       763 
          FGFR1_HUMAN   464 ELPEDPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 764
               SCOP domains d3rhxa_ A: Fibroblast growth factor receptor 1                                                                                                                                                                                                                                                                SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..........hhh.eeeeeeeee....eeeeeeee.........eeeeeeee.....hhhhhhhhhhhhhhhhhhh.......eeeee......eeeee.....hhhhhhhh....------------....hhhhhhhhhhhhhhhhhhhhhh.......hhh.eee.....eee.......hhhhh..........hhhhhhhhhhhhhh..hhhhhhhhhhhhhhhhhh.........hhhhhhhhhhh..........hhhhhhhhhhhh..hhhhh.hhhhhhhhhhhhhhh.... Sec.struct. author
             SAPs(SNPs) (1) ------L------------T------R-----------------------------T-----------------V-------K--------------M---------------------------------------------M----------N--RGY---TK---------------------------E-------L-R---KP-------------F-R----GF---------R---------------R--H-KY-------------------S------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------------------------------------------------------------------------------------------------------------------------------------------------------Q--------------------------------------------------------------------------------S---------------V--S------------------------------------------ SAPs(SNPs) (2)
                    PROSITE --------------------PROTEIN_KINASE_ATP             --------------------------------------------------------------------------------------------------------PROTEIN_KINAS------------------------------------------------------------------------------------------------------------------------------------- PROSITE
                 Transcript ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                 3rhx A 464 ELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP------------EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 764
                                   473       483       493       503       513       523       533       543       553       563       573     |   -       593       603       613       623       633       643       653       663       673       683       693       703       713       723       733       743       753       763 
                                                                                                                                             579          592

Chain B from PDB  Type:PROTEIN  Length:275
 aligned with FGFR1_HUMAN | P11362 from UniProtKB/Swiss-Prot  Length:822

    Alignment length:301
                                   470       480       490       500       510       520       530       540       550       560       570       580       590       600       610       620       630       640       650       660       670       680       690       700       710       720       730       740       750       760 
          FGFR1_HUMAN   461 SEYELPEDPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 761
               SCOP domains d3rhxb_ B: Fibroblast growth factor rece    ptor 1                                                                                                                                                                                                                                                            SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
           Pfam domains (1) -----------------Pkinase_Tyr-3rhxB01 B:4    78-754                                                                                                                                                                                                                                                    ------- Pfam domains (1)
           Pfam domains (2) -----------------Pkinase_Tyr-3rhxB02 B:4    78-754                                                                                                                                                                                                                                                    ------- Pfam domains (2)
         Sec.struct. author .............hhh.eeeeeeeee....eeeeeeee..----...eeeeeeee.....hhhhhhhhhhhhhhhhhhh.......eeeee......eeeee.....hhhhhhhh..----------------..hhhhhhhhhhhhhhhhhhhhhh.......hhh.eee.....eee......------..........hhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhh.........hhhhhhhhhhh..........hhhhhhhhhhhh..hhhhh.hhhhhhhhhhhhhhhh Sec.struct. author
             SAPs(SNPs) (1) ---------L------------T------R-----------------------------T-----------------V-------K--------------M---------------------------------------------M----------N--RGY---TK---------------------------E-------L-R---KP-------------F-R----GF---------R---------------R--H-KY-------------------S---------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) -----------------------------------------------------------------------------------------------------------------------------------------------------------------Q--------------------------------------------------------------------------------S---------------V--S--------------------------------------- SAPs(SNPs) (2)
                    PROSITE -----------------------PROTEIN_KINASE_ATP             --------------------------------------------------------------------------------------------------------PROTEIN_KINAS---------------------------------------------------------------------------------------------------------------------------------- PROSITE
                 Transcript ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                 3rhx B 461 SEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGL----PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR----------------QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 761
                                   470       480       490       500    |  510       520       530       540       550       560       570      |  -         -   |   600       610       620       630       640    |    - |     660       670       680       690       700       710       720       730       740       750       760 
                                                                 500  505                                                                     577              594                                                645    652

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (1, 2)

CATH Domains (0, 0)

Pfam Domains (1, 2)

Gene Ontology (99, 99)

Asymmetric Unit(hide GO term definitions)

Chain A,B (FGFR1_HUMAN | P11362)

molecular function
	GO:0016303	1-phosphatidylinositol-3-kinase activity	Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol + ATP = a 1-phosphatidyl-1D-myo-inositol 3-phosphate + ADP + 2 H(+).
	GO:0005524	ATP binding	Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
	GO:0005088	Ras guanyl-nucleotide exchange factor activity	Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
	GO:0050839	cell adhesion molecule binding	Interacting selectively and non-covalently with a cell adhesion molecule.
	GO:0017134	fibroblast growth factor binding	Interacting selectively and non-covalently with a fibroblast growth factor.
	GO:0005007	fibroblast growth factor-activated receptor activity	Combining with a fibroblast growth factor and transmitting the signal across the plasma membrane to initiate a change in cell activity.
	GO:0008201	heparin binding	Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
	GO:0042802	identical protein binding	Interacting selectively and non-covalently with an identical protein or proteins.
	GO:0016301	kinase activity	Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
	GO:0000166	nucleotide binding	Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+).
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0032403	protein complex binding	Interacting selectively and non-covalently with any protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0042803	protein homodimerization activity	Interacting selectively and non-covalently with an identical protein to form a homodimer.
	GO:0004672	protein kinase activity	Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
	GO:0004713	protein tyrosine kinase activity	Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
	GO:0016740	transferase activity	Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
	GO:0004714	transmembrane receptor protein tyrosine kinase activity	Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
biological process
	GO:0000165	MAPK cascade	An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
	GO:0001525	angiogenesis	Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
	GO:0060117	auditory receptor cell development	The process whose specific outcome is the progression of an auditory receptor cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
	GO:0048514	blood vessel morphogenesis	The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood.
	GO:0007420	brain development	The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
	GO:0060445	branching involved in salivary gland morphogenesis	The process in which the branching structure of the salivary gland is generated and organized.
	GO:0048469	cell maturation	A developmental process, independent of morphogenetic (shape) change, that is required for a cell to attain its fully functional state.
	GO:0016477	cell migration	The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
	GO:0021954	central nervous system neuron development	The process whose specific outcome is the progression of a neuron whose cell body is located in the central nervous system, from initial commitment of the cell to a neuronal fate, to the fully functional differentiated neuron.
	GO:0002062	chondrocyte differentiation	The process in which a chondroblast acquires specialized structural and/or functional features of a chondrocyte. A chondrocyte is a polymorphic cell that forms cartilage.
	GO:0043009	chordate embryonic development	The process whose specific outcome is the progression of the embryo over time, from zygote formation through a stage including a notochord and neural tube until birth or egg hatching.
	GO:0030326	embryonic limb morphogenesis	The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping.
	GO:0008543	fibroblast growth factor receptor signaling pathway	The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
	GO:0035607	fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development	The series of molecular signals generated as a consequence of a fibroblast growth factor-type receptor binding to one of its physiological ligands, which contributes to the progression of the orbitofrontal cortex over time from its initial formation until its mature state.
	GO:0048699	generation of neurons	The process in which nerve cells are generated. This includes the production of neuroblasts and their differentiation into neurons.
	GO:0001701	in utero embryonic development	The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
	GO:0042472	inner ear morphogenesis	The process in which the anatomical structures of the inner ear are generated and organized. The inner ear is the structure in vertebrates that contains the organs of balance and hearing. It consists of soft hollow sensory structures (the membranous labyrinth) containing fluid (endolymph) surrounded by fluid (perilymph) and encased in a bony cavity (the bony labyrinth). It consists of two chambers, the sacculus and utriculus, from which arise the cochlea and semicircular canals respectively.
	GO:0030324	lung development	The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
	GO:0060484	lung-associated mesenchyme development	The biological process whose specific outcome is the progression of a lung-associated mesenchyme from an initial condition to its mature state. This process begins with the formation of lung-associated mesenchyme and ends with the mature structure. Lung-associated mesenchyme is the tissue made up of loosely connected mesenchymal cells in the lung.
	GO:0048762	mesenchymal cell differentiation	The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types.
	GO:0030901	midbrain development	The process whose specific outcome is the progression of the midbrain over time, from its formation to the mature structure. The midbrain is the middle division of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes a ventral part containing the cerebral peduncles and a dorsal tectum containing the corpora quadrigemina and that surrounds the aqueduct of Sylvius connecting the third and fourth ventricles).
	GO:0042474	middle ear morphogenesis	The process in which the anatomical structures of the middle ear are generated and organized. The middle ear is the air-filled cavity within the skull of vertebrates that lies between the outer ear and the inner ear. It is linked to the pharynx (and therefore to outside air) via the Eustachian tube and in mammals contains the three ear ossicles, which transmit auditory vibrations from the outer ear (via the tympanum) to the inner ear (via the oval window).
	GO:0021837	motogenic signaling involved in postnatal olfactory bulb interneuron migration	The signaling that results in the stimulation of cell movement in the rostral migratory stream.
	GO:0010629	negative regulation of gene expression	Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
	GO:0045668	negative regulation of osteoblast differentiation	Any process that stops, prevents, or reduces the frequency, rate or extent of osteoblast differentiation.
	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0001764	neuron migration	The characteristic movement of an immature neuron from germinal zones to specific positions where they will reside as they mature.
	GO:0031175	neuron projection development	The process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
	GO:0021769	orbitofrontal cortex development	The progression of the orbitofrontal cortex over time from its initial formation until its mature state. The orbitofrontal cortex is a cerebral cortex region located in the frontal lobe.
	GO:0001759	organ induction	The interaction of two or more cells or tissues that causes them to change their fates and specify the development of an organ.
	GO:0042473	outer ear morphogenesis	The process in which the anatomical structures of the outer ear are generated and organized. The outer ear is the part of the ear external to the tympanum (eardrum). It consists of a tube (the external auditory meatus) that directs sound waves on to the tympanum, and may also include the external pinna, which extends beyond the skull.
	GO:0048339	paraxial mesoderm development	The process whose specific outcome is the progression of the paraxial mesoderm over time, from its formation to the mature structure. The paraxial mesoderm is the mesoderm located bilaterally adjacent to the notochord and neural tube.
	GO:0018108	peptidyl-tyrosine phosphorylation	The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
	GO:0046854	phosphatidylinositol phosphorylation	The process of introducing one or more phosphate groups into a phosphatidylinositol, any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol.
	GO:0036092	phosphatidylinositol-3-phosphate biosynthetic process	The chemical reactions and pathways resulting in the formation of phosphatidylinositol-3-phosphate, a phosphatidylinositol monophosphate carrying the phosphate group at the 3-position.
	GO:0048015	phosphatidylinositol-mediated signaling	A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
	GO:0016310	phosphorylation	The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
	GO:0043547	positive regulation of GTPase activity	Any process that activates or increases the activity of a GTPase.
	GO:0043406	positive regulation of MAP kinase activity	Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
	GO:0043410	positive regulation of MAPK cascade	Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.
	GO:0090080	positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway	The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands resulting in an increase in the rate or frequency of a MAPKKK cascade.
	GO:0060045	positive regulation of cardiac muscle cell proliferation	Any process that activates or increases the frequency, rate or extent of cardiac muscle cell proliferation.
	GO:0045787	positive regulation of cell cycle	Any process that activates or increases the rate or extent of progression through the cell cycle.
	GO:0008284	positive regulation of cell proliferation	Any process that activates or increases the rate or extent of cell proliferation.
	GO:2000546	positive regulation of endothelial cell chemotaxis to fibroblast growth factor	Any process that activates or increases the frequency, rate or extent of endothelial cell chemotaxis to fibroblast growth factor.
	GO:0002053	positive regulation of mesenchymal cell proliferation	The process of activating or increasing the rate or extent of mesenchymal cell proliferation. Mesenchymal cells are loosely organized embryonic cells.
	GO:0045666	positive regulation of neuron differentiation	Any process that activates or increases the frequency, rate or extent of neuron differentiation.
	GO:0010976	positive regulation of neuron projection development	Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
	GO:0010863	positive regulation of phospholipase C activity	Any process that increases the rate of phospholipase C activity.
	GO:0010518	positive regulation of phospholipase activity	Any process that increases the frequency, rate or extent of phospholipase activity, the hydrolysis of a phospholipid.
	GO:0046777	protein autophosphorylation	The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
	GO:0006468	protein phosphorylation	The process of introducing a phosphate group on to a protein.
	GO:0060665	regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling	Any process that modulates the rate, frequency, or extent of branching involved in salivary gland morphogenesis as a result of signals being generated by the mesenchyme and received and interpreted by the salivary gland epithelium.
	GO:0045595	regulation of cell differentiation	Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features.
	GO:0042127	regulation of cell proliferation	Any process that modulates the frequency, rate or extent of cell proliferation.
	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
	GO:0010468	regulation of gene expression	Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
	GO:0048378	regulation of lateral mesodermal cell fate specification	Any process that modulates the frequency, rate or extent of lateral mesoderm cell fate specification.
	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	Any process that modulates the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
	GO:0051930	regulation of sensory perception of pain	Any process that modulates the frequency, rate or extent of the sensory perception of pain, the series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal.
	GO:0072091	regulation of stem cell proliferation	Any process that modulates the frequency, rate or extent of stem cell proliferation. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
	GO:0006355	regulation of transcription, DNA-templated	Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
	GO:0007435	salivary gland morphogenesis	The process in which the anatomical structures of the salivary gland are generated and organized.
	GO:0007605	sensory perception of sound	The series of events required for an organism to receive an auditory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Sonic stimuli are detected in the form of vibrations and are processed to form a sound.
	GO:0001501	skeletal system development	The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
	GO:0048705	skeletal system morphogenesis	The process in which the anatomical structures of the skeleton are generated and organized.
	GO:0019827	stem cell population maintenance	The process by which an organism or tissue maintains a population of stem cells of a single type. This can be achieved by a number of mechanisms: stem cell asymmetric division maintains stem cell numbers; stem cell symmetric division increases them; maintenance of a stem cell niche maintains the conditions for commitment to the stem cell fate for some types of stem cell; stem cells may arise de novo from other cell types.
	GO:0006351	transcription, DNA-templated	The cellular synthesis of RNA on a template of DNA.
	GO:0001657	ureteric bud development	The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure.
	GO:0021847	ventricular zone neuroblast division	The proliferation of neuroblasts in the ventricular zone of the cerebral cortex. The neuronal progenitors of these cells will migrate radially.
cellular component
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0031410	cytoplasmic vesicle	A vesicle found in the cytoplasm of a cell.
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0016021	integral component of membrane	The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0005887	integral component of plasma membrane	The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
	GO:0043235	receptor complex	Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (3, 8)

Sites (8, 8)

SS Bonds (0, 0)

Cis Peptide Bonds (0, 0)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (33, 66)

PROSITE Motifs (2, 4)

Exons (0, 0)

Sequences/Alignments

Classification and Annotation

SCOP Domains (1, 2)

CATH Domains (0, 0)

Pfam Domains (1, 2)

Gene Ontology (99, 99)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File